Chimerix to Present at 2021 Wedbush PacGrow Healthcare Conference
August 03, 2021 07:00 ET
|
Chimerix, Inc.
DURHAM, N.C., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
Chimerix to Report Second Quarter 2021 Financial Results and Provide an Operational Update on August 5, 2021
July 29, 2021 07:00 ET
|
Chimerix, Inc.
DURHAM, N.C., July 29, 2021 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
Chimerix Receives U.S. Food and Drug Administration Approval for TEMBEXA® (brincidofovir) for the Treatment of Smallpox
June 04, 2021 14:10 ET
|
Chimerix, Inc.
DURHAM, N.C., June 04, 2021 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
Chimerix to Present at Jefferies Virtual Healthcare Conference
May 25, 2021 08:00 ET
|
Chimerix, Inc.
DURHAM, N.C., May 25, 2021 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
Chimerix Announces Upcoming Presentations at the American Society of Clinical Oncology 2021 Annual Meeting
May 19, 2021 17:01 ET
|
Chimerix, Inc.
DURHAM, N.C., May 19, 2021 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
Chimerix to Present at Cowen and Company 2nd Annual Virtual Oncology Innovation Summit
May 13, 2021 07:00 ET
|
Chimerix, Inc.
DURHAM, N.C., May 13, 2021 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
Chimerix Reports First Quarter 2021 Financial Results and Provides Operational Update
May 06, 2021 07:00 ET
|
Chimerix, Inc.
– BCV PDUFA Date Set for July 7 and ONC201 Blinded Independent Central Review Expected in Second Half of 2021 – – DSTAT COVID 19 Trial Advances to Cohort 3 at Higher Dose – – Conference Call at 8:30...
Chimerix to Report First Quarter 2021 Financial Results and Provide an Operational Update on May 6, 2021
April 29, 2021 07:00 ET
|
Chimerix, Inc.
DURHAM, N.C., April 29, 2021 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
Chimerix Appoints Vicki Vakiener to Board of Directors
April 26, 2021 07:00 ET
|
Chimerix, Inc.
DURHAM, N.C., April 26, 2021 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...
Chimerix Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021
April 08, 2021 16:01 ET
|
Chimerix, Inc.
DURHAM, N.C., April 08, 2021 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases,...